EdgarLookup

Moore Paul Andrew

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to Moore Paul Andrew. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

ZYME
Company Title Type Shares Price Value Date
ZYME Chief Scientific Officer Option Exercise 17,166 Jan 6, 2025
ZYME Chief Scientific Officer Sale 7,460 $10.65 $79,449 Jan 8, 2024